Pantoprazole Use in End-Stage Renal Disease (ESRD)

Comparison to Other Medications in ESRD

• Unlike certain opioids that require dose reduction when GFR is <60 ml/min/1.73 m² and careful use in ESRD, pantoprazole requires no such adjustment, as stated by the American Journal of Kidney Diseases 1
• In contrast to medications like metformin, which should be avoided in severe renal impairment, pantoprazole maintains its safety profile in ESRD, according to Diabetes Care 2
• The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines emphasize the importance of dose adjustments for many medications in chronic kidney disease (CKD), but pantoprazole is not among those requiring modification, as noted by the American Journal of Kidney Diseases 1